Survey of Australian inpatients on vaccination status and perceptions of influenza vaccination

Consultant Pharmacist

Volumn 27, Issue 8, 2012, Pages 553-563

  Loke, Xin Yee ^c   Tran, Winnie ^a   Alderman, Christopher P ^a,b  

^a REPATRIATION GENERAL HOSPITAL   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c NONE

Author keywords

Attitudes; Hospital inpatients; Influenza; Vaccination; World Health Organization

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ADULT; AGE; AGED; ARTICLE; AUSTRALIA; DRUG EFFICACY; FEMALE; HEALTH SURVEY; HEPATITIS B VIRUS; HOSPITAL PATIENT; HUMAN; INFLUENZA VACCINATION; MALE; MEDICAL AUDIT; PATIENT ATTITUDE; PERCEPTION; PHARMACIST; PROSPECTIVE STUDY; RISK ASSESSMENT; SELF REPORT; VARICELLA ZOSTER VIRUS;

AGE FACTORS; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HOSPITALS, TEACHING; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PHARMACEUTICAL SERVICES; PHARMACISTS; PROFESSIONAL ROLE; PROSPECTIVE STUDIES; QUESTIONNAIRES; SOUTH AUSTRALIA; VACCINES;

EID: 84864578511     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2012.553     Document Type: Article

References (34)

1. Fauci AS. Seasonal and pandemic influenza preparedness: science and countermeasures. J Infect Dis 2006;194:S73-S76. (Pubitemid 44630949)
2. Australian Institute of Health and Welfare 2010. Australian hospital statistics 2008-09. Health services series no. 17. Cat. no. HSE 84. Canberra, Australia: AIHW.
3. Australian Medical Council Limited. Good Medical Practice: A Code of Conduct for Doctors in Australia; 2009. Available at 〈http://www.amc.org. au/index.php/about/good-medicalpractice〉.
4. Jefferson T, Di Pietrantonj C, Rivetti A et al. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2010;7:CD001269.
5. Brotherton J, McIntyre P, Puech M et al. Vaccine preventable diseases and vaccination coverage in Australia, 2001 to 2002. Communicable Diseases Intelligence 2004;28 (suppl 2.)
6. Winfield AJ, Rees JA, Smith I. Pharmaceutical Practice. 4th ed. Edinburgh, Scotland: Churchill-Livingston; 2009.
7. Irwin DE, Weatherby LB, Huang W et al. Impact of patient characteristics on the risk of influenza/ILI-related complications. BMC Health Serv Res 2001;1:8.
8. Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982;4:25.
9. Nichol KL. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003;348:1322-32. (Pubitemid 36384099)
10. Nichol KL. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994;331:778-84. (Pubitemid 24284768)
11. National Health and Medical Research Council. The Australian Immunisation Handbook. 7th ed. Canberra, Australia: Australian Government Publishing Service; 2000.
12. Mogasale V, Barendregt J. Cost-effectiveness of influenza vaccination of people aged 50-64 years in Australia: results are inconclusive. Aust N Z J Public Health 2011;35:180-6.
13. Program IA. Fact Sheet for Immunisation Providers Influenza Vaccination 2011. Canberra, Australia: Australian Government Department of Health and Ageing; 2011.
14. Galloway L, Toms L, Archer J et al. 2006 Adult Vaccination Survey: Coverage and Valid Use - Summary Results. Canberra, Australia: Australian Government Department of Health and Ageing; 2008.
15. Steiner I. Can vaccinating older adults against varicella zoster virus prevent herpes zoster and postherpetic neuralgia? Nat Clin Pract Neurol 2005;1:18-9.
16. Andrews R, Counahan ML, Hogg GG et al. Effectiveness of a publicly funded pneumococcal vaccination program against invasive pneumococcal disease among the elderly in Victoria, Australia. Vaccine 2004;23:132-8. (Pubitemid 39505081)
17. Rushdy AA, White JM, Ramsay ME et al. Tetanus in England and Wales, 1984-2000. Epidemiol Infect 2003;130:71-7. (Pubitemid 36231225)
18. Michel ML, Tiollais P. Hepatitis B vaccines: protective efficacy and therapeutic potential. Pathologie Biologie 2010;58:288-95.
19. Kohlhammer Y, Schnoor M, Schwartz M et al. Determinants of influenza and pneumococcal vaccination in elderly people: a systematic review. Public Health 2007;121:742-51. (Pubitemid 47278992)
20. Horby PW, Williams A, Burgess MA et al. Prevalence and determinants of influenza vaccination in Australians aged 40 years and over - a national survey. Aust N Z J Public Health 2005;29:35-7. (Pubitemid 40378669)
21. World Health Organization. Prevention and control of influenza pandemics and annual epidemics (agenda item 14.14). Fifty-Sixth World Health Assembly; Geneva, Switzerland (WHA56.19); 2003.
22. Nichol K. The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. Vaccine 2003;21:1769-75.
23. Fedson DS, Christie P. Pneumococcal vaccination and pneumonia: even a low level of clinical effectiveness is highly costeffective. Clin Infect Dis 2001;33:2078-9.
24. Rivetti D, Jefferson T, Rivetti A et al. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005;366:1165-74. (Pubitemid 41393594)
25. Lundbergh P, Christenson B. Comparison between cohorts vaccinated and unvaccinated against influenza and pneumococcal infection. Epidemiol Infect 2002;129:515-24. (Pubitemid 36157675)
26. Ozasa K, Matsui D, Shigeta M et al. Factors associated with influenza vaccination: status of residents of a rural community in Japan. BMC Public Health 2011.
27. Müller D, Wutzler P, Szucs TD. Influenza vaccination coverage rates in Germany: a population-based cross-sectional analysis of the seasons 2002/2003 and 2003/2004. Med Klin (Munich) 2005;100:6-13 (Pubitemid 40179033)
28. Chapman G. Predictors of influenza vaccine acceptance among healthy adults. Prev Med 1999;29:249-62. (Pubitemid 29470267)
29. Fine MJ, Janosky JE, Zimmerman RK et al. What affects influenza vaccination rates among older patients? An analysis from inner-city, suburban, rural, and Veterans Affairs practices. Am J Med 2003;114:31-8. (Pubitemid 36126513)
30. Nichol KL. Influenza vaccination in the elderly: impact on hospitalisation and mortality. Drugs Aging 2005;22:495-515. (Pubitemid 41003063)
31. Nowalk MP, Zimmerman RK, Shen S et al. Barriers to pneumococcal and influenza vaccination in older communitydwelling adults (2000-2001). J Am Geriatr Soc 2004;52:25-30. (Pubitemid 38090386)
32. CDC. Reasons reported by Medicare beneficiaries for not receiving influenza and pneumococcal vaccinations-United States, 1996. MMWR 1999;48:886.
33. Fiore AE, Uyeki TM, Broder K et al., Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 2007;56(RR-6):1-54.
34. Kelly HA, Skull SA, Andrews RM et al. Validity of self-reported influenza and pneumococcal vaccination status among a cohort of hospitalized elderly inpatients. Vaccine 2007;25:4775-83. (Pubitemid 46818615)